OLIGOMERIC A-BETA IN THE DIAGNOSIS, PROGNOSIS, AND MONITORING OF ALZHEIMER'S DISEASE
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Oct 17, 2013
app pub date -
Mar 13, 2013
filing date -
Mar 13, 2012
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention provides methods for diagnosis, prognosis and monitoring of Alzheimer's disease. The methods involve measuring the amounts of combined monomeric and oligomeric Aβ and amount of monomeric Aβ in samples obtained from a subject, and determining a ratio. The ratio can be used in diagnosing, prognosing, and/or monitoring Alzheimer's disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully